Correction to: Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells (Pharmaceutics, (2022), 14, 10, (2212), 10.3390/pharmaceutics14102212)

Dimakatso Mokoena; Blassan P. George; Heidi Abrahamse

doi:10.3390/pharmaceutics17040402

Correction to: Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells (Pharmaceutics, (2022), 14, 10, (2212), 10.3390/pharmaceutics14102212)

Dimakatso Mokoena
, Blassan P. George
, Heidi Abrahamse

University of Johannesburg

Research output: Contribution to journal › Comment/debate

Abstract

In the original publication [1], there was a mistake in Figure 4 as published. Inadvertently, the wrong image was included for Mitotracker—8 h. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction has been approved by the Academic Editor. The original publication has also been updated.

Original language	English
Article number	402
Journal	Pharmaceutics
Volume	17
Issue number	4
DOIs	https://doi.org/10.3390/pharmaceutics17040402
Publication status	Published - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.3390/pharmaceutics17040402

Cite this

@article{06b1213de4c8400daec07fc9c38d2dfe,

title = "Correction to: Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells (Pharmaceutics, (2022), 14, 10, (2212), 10.3390/pharmaceutics14102212)",

abstract = "In the original publication [1], there was a mistake in Figure 4 as published. Inadvertently, the wrong image was included for Mitotracker—8 h. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction has been approved by the Academic Editor. The original publication has also been updated.",

author = "Dimakatso Mokoena and George, \{Blassan P.\} and Heidi Abrahamse",

note = "Publisher Copyright: {\textcopyright} 2025 by the authors.",

year = "2025",

month = apr,

doi = "10.3390/pharmaceutics17040402",

language = "English",

volume = "17",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "4",

}

Correction to: Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells (Pharmaceutics, (2022), 14, 10, (2212), 10.3390/pharmaceutics14102212). / Mokoena, Dimakatso; George, Blassan P.; Abrahamse, Heidi.
In: Pharmaceutics, Vol. 17, No. 4, 402, 04.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells (Pharmaceutics, (2022), 14, 10, (2212), 10.3390/pharmaceutics14102212)

AU - Mokoena, Dimakatso

AU - George, Blassan P.

AU - Abrahamse, Heidi

PY - 2025/4

Y1 - 2025/4

N2 - In the original publication [1], there was a mistake in Figure 4 as published. Inadvertently, the wrong image was included for Mitotracker—8 h. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction has been approved by the Academic Editor. The original publication has also been updated.

AB - In the original publication [1], there was a mistake in Figure 4 as published. Inadvertently, the wrong image was included for Mitotracker—8 h. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction has been approved by the Academic Editor. The original publication has also been updated.

UR - https://www.scopus.com/pages/publications/105002702909

U2 - 10.3390/pharmaceutics17040402

DO - 10.3390/pharmaceutics17040402

M3 - Comment/debate

AN - SCOPUS:105002702909

SN - 1999-4923

VL - 17

JO - Pharmaceutics

JF - Pharmaceutics

IS - 4

M1 - 402

ER -

Correction to: Conjugation of Hypericin to Gold Nanoparticles for Enhancement of Photodynamic Therapy in MCF-7 Breast Cancer Cells (Pharmaceutics, (2022), 14, 10, (2212), 10.3390/pharmaceutics14102212)

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this